Clinical Trials

Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA. Read More

Appello Pharmaceuticals Inc. begins trial of a drug candidate that improves relief from symptoms of Parkinson’s disease without debilitating side effects. Read More

Scarcely a year after its national launch, the “All of Us” research program, which aims to accelerate the prevention and treatment of disease, has enrolled more than 230,000 research participants — more than a fifth of its recruitment goal of 1 million people. All Read More

Clinicians, investigators and cancer patients now have access to a new online search tool that provides more detailed information about clinical research trials available for cancer patients. Read More

For more than a dozen years Buz Harrison, a Nashville-based media producer, has been plagued by gastroesophageal reflux disease (GERD). Read More

Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this. Read More

An initiative promoted by the Vanderbilt Institute of Clinical and Translational Research (VICTR) offers an opportunity to reduce by more than half the time it takes to negotiate clinical trial contracts. Read More

As the number of opportunities to participate in research studies continues to grow, the Vanderbilt Human Research Protection Program (HRPP) would like study participants to be aware of the Research Subjects’ Bill of Rights. Read More